• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Management of COVID-19: the Zhejiang experience].[新型冠状病毒肺炎的管理:浙江经验]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(2):147-157. doi: 10.3785/j.issn.1008-9292.2020.02.02.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Detection and analysis of nucleic acid in various biological samples of COVID-19 patients.检测和分析 COVID-19 患者各种生物样本中的核酸。
Travel Med Infect Dis. 2020 Sep-Oct;37:101673. doi: 10.1016/j.tmaid.2020.101673. Epub 2020 Apr 18.
4
Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China.中国浙江省 465 例新冠肺炎(COVID-19)住院病例的流行病学、临床和病毒学特征。
Influenza Other Respir Viruses. 2020 Sep;14(5):564-574. doi: 10.1111/irv.12758. Epub 2020 May 19.
5
Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019.痰和粪便中的病毒核酸与血清特异性 IgM/IgG 对 2019 年冠状病毒病的诊断价值。
Front Cell Infect Microbiol. 2020 Aug 6;10:445. doi: 10.3389/fcimb.2020.00445. eCollection 2020.
6
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.抗病毒联合治疗在新冠病毒感染有症状患者中的安全性和有效性 - 一项随机对照试验(SEV-COVID 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 20;21(1):866. doi: 10.1186/s13063-020-04774-5.
7
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.高剂量干扰素β-1a与低剂量干扰素β-1a(基础治疗方案)相比对中度至重度COVID-19的有益效果研究:一项随机对照试验研究方案的结构化总结
Trials. 2020 Oct 26;21(1):880. doi: 10.1186/s13063-020-04812-2.
8
The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial.新型冠状病毒病患者核酸检测由阴转阳的机制及临床转归和法匹拉韦的疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):488. doi: 10.1186/s13063-020-04430-y.
9
The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.初步筛查和诊断的意义:中国湖南 33 例 SARS-CoV-2 感染轻症患者的临床特征。
J Clin Virol. 2020 Jul;128:104397. doi: 10.1016/j.jcv.2020.104397. Epub 2020 Apr 30.
10
COVID-19 in Children: Clinical Approach and Management.儿童 COVID-19:临床方法与管理。
Indian J Pediatr. 2020 Jun;87(6):433-442. doi: 10.1007/s12098-020-03292-1. Epub 2020 Apr 27.

引用本文的文献

1
Exploring the oncogenic potential of SARS-CoV-2 in the gastrointestinal tract.探索严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在胃肠道中的致癌潜力。
World J Gastroenterol. 2025 Aug 21;31(31):105665. doi: 10.3748/wjg.v31.i31.105665.
2
The Mystery of Certain Strains in the Treatment of Gastrointestinal Symptoms of COVID-19: A Review.新冠病毒感染胃肠道症状治疗中某些毒株的奥秘:综述
Microorganisms. 2025 Apr 19;13(4):944. doi: 10.3390/microorganisms13040944.
3
Human microbiome in post-acute COVID-19 syndrome (PACS).新冠后急性综合征(PACS)中的人类微生物组
Curr Res Microb Sci. 2024 Nov 28;8:100324. doi: 10.1016/j.crmicr.2024.100324. eCollection 2025.
4
Probiotic Therapy of Gastrointestinal Symptoms During COVID-19 Infection: A Randomized, Double-Blind, Placebo-Controlled, Remote Study.COVID-19 感染期间胃肠道症状的益生菌治疗:一项随机、双盲、安慰剂对照、远程研究。
Nutrients. 2024 Nov 20;16(22):3970. doi: 10.3390/nu16223970.
5
Probiotics for preventing or treating COVID-19; a systematic review of research evidence and meta-analyses of efficacy for preventing death, severe disease, or disease progression.用于预防或治疗新型冠状病毒肺炎的益生菌:研究证据的系统评价及预防死亡、重症或疾病进展疗效的荟萃分析
Wellcome Open Res. 2022 Dec 5;7:292. doi: 10.12688/wellcomeopenres.18526.1. eCollection 2022.
6
The Influence of Probiotic Lactobacilli on COVID-19 and the Microbiota.益生菌乳杆菌对 COVID-19 和微生物群的影响。
Nutrients. 2024 Apr 30;16(9):1350. doi: 10.3390/nu16091350.
7
Impact of COVID-19 on Pediatric Inflammatory Bowel Diseases-From Expectations to Reality.新冠病毒病对儿童炎症性肠病的影响——从期望到现实
J Pers Med. 2024 Apr 9;14(4):399. doi: 10.3390/jpm14040399.
8
Food science and COVID-19.食品科学与2019冠状病毒病
Food Sci Hum Wellness. 2021 Jan;10(1):1-5. doi: 10.1016/j.fshw.2020.08.005. Epub 2020 Sep 23.
9
Bioactive compounds and probiotics-a ray of hope in COVID-19 management.生物活性化合物与益生菌——新冠疫情应对中的一线希望
Food Sci Hum Wellness. 2021 Mar;10(2):131-140. doi: 10.1016/j.fshw.2021.02.001. Epub 2021 Mar 22.
10
Digestive manifestations of Covid-19 in children: a retrospective study.儿童新型冠状病毒病的消化系统表现:一项回顾性研究。
Afr Health Sci. 2023 Sep;23(3):181-185. doi: 10.4314/ahs.v23i3.22.

本文引用的文献

1
A novel coronavirus outbreak of global health concern.一场引发全球卫生关注的新型冠状病毒疫情。
Lancet. 2020 Feb 15;395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9. Epub 2020 Jan 24.
2
Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza A (H7N9): a cohort study.血浆置换和持续静脉-静脉血液滤过治疗重症甲型H7N9禽流感的队列研究
Ther Apher Dial. 2015 Apr;19(2):178-84. doi: 10.1111/1744-9987.12240. Epub 2014 Nov 3.
3
Clinical findings in 111 cases of influenza A (H7N9) virus infection.111 例甲型 H7N9 流感病毒感染的临床特征。
N Engl J Med. 2013 Jun 13;368(24):2277-85. doi: 10.1056/NEJMoa1305584. Epub 2013 May 22.
4
Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome.人感染新型禽流感 A(H7N9)病毒来自湿市场家禽:临床分析和病毒基因组特征。
Lancet. 2013 Jun 1;381(9881):1916-25. doi: 10.1016/S0140-6736(13)60903-4. Epub 2013 Apr 25.

[新型冠状病毒肺炎的管理:浙江经验]

[Management of COVID-19: the Zhejiang experience].

作者信息

Xu Kaijin, Cai Hongliu, Shen Yihong, Ni Qin, Chen Yu, Hu Shaohua, Li Jianping, Wang Huafen, Yu Liang, Huang He, Qiu Yunqing, Wei Guoqing, Fang Qiang, Zhou Jianying, Sheng Jifang, Liang Tingbo, Li Lanjuan

机构信息

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.

出版信息

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(2):147-157. doi: 10.3785/j.issn.1008-9292.2020.02.02.

DOI:10.3785/j.issn.1008-9292.2020.02.02
PMID:32391658
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8800711/
Abstract

The current epidemic situation of coronavirus disease 2019 (COVID-19) still remained severe. As the National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital of Zhejiang University School of Medicine is the primary medical care center for COVID-19 in Zhejiang province. Based on the present expert consensus carried out by National Health Commission and National Administration of Traditional Chinese Medicine, our team summarized and established an effective treatment strategy centered on "Four-Anti and Two-Balance" for clinical practice. The "Four-Anti and Two-Balance" strategy included antivirus, anti-shock, anti-hyoxemia, anti-secondary infection, and maintaining of water, electrolyte and acid base balance and microecological balance. Meanwhile, integrated multidisciplinary personalized treatment was recommended to improve therapeutic effect. The importance of early viralogical detection, dynamic monitoring of inflammatory indexes and chest radiograph was emphasized in clinical decision-making. Sputum was observed with the highest positive rate of RT-PCR results. Viral nucleic acids could be detected in 10%patients' blood samples at acute period and 50%of patients had positive RT-PCR results in their feces. We also isolated alive viral strains from feces, indicating potential infectiousness of feces.Dynamic cytokine detection was necessary to timely identifying cytokine storms and application of artificial liver blood purification system. The "Four-Anti and Two-Balance" strategy effectively increased cure rate and reduced mortality. Early antiviral treatment could alleviate disease severity and prevent illness progression, and we found lopinavir/ritonavir combined with abidol showed antiviral effects in COVID-19. Shock and hypoxemia were usually caused by cytokine storms. The artificial liver blood purification system could rapidly remove inflammatory mediators and block cytokine storm.Moreover, it also favored the balance of fluid, electrolyte and acid-base and thus improved treatment efficacy in critical illness. For cases of severe illness, early and also short period of moderate glucocorticoid was supported. Patients with oxygenation index below 200 mmHg should be transferred to intensive medical center. Conservative oxygen therapy was preferred and noninvasive ventilation was not recommended. Patients with mechanical ventilation should be strictly supervised with cluster ventilator-associated pneumonia prevention strategies. Antimicrobial prophylaxis was not recommended except for patients with long course of disease, repeated fever and elevated procalcitonin (PCT), meanwhile secondary fungal infection should be concerned.Some patients with COVID-19 showed intestinal microbial dysbiosis with decreased probiotics such as and , so nutritional and gastrointestinal function should be assessed for all patients.Nutritional support and application of prebiotics or probiotics were suggested to regulate the balance of intestinal microbiota and reduce the risk of secondary infection due to bacterial translocation. Anxiety and fear were common in patients with COVID-19. Therefore,we established dynamic assessment and warning for psychological crisis. We also integrated Chinese medicine in treatment to promote disease rehabilitation through classification methods of traditional Chinese medicine. We optimized nursing process for severe patients to promote their rehabilitation. It remained unclear about viral clearance pattern after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Therefore, two weeks' quarantine for discharged patients was required and a regular following up was also needed.The Zhejiang experience and suggestions have been implemented in our center and achieved good results. However, since COVID-19 was a newly emerging disease, more work was warranted to improve strategies of prevention, diagnosis and treatment for COVID-19.

摘要

新型冠状病毒肺炎(COVID-19)当前疫情形势依然严峻。浙江大学医学院附属第一医院作为国家传染病临床研究中心,是浙江省COVID-19的主要医疗救治中心。基于国家卫生健康委员会和国家中医药管理局目前达成的专家共识,我们团队总结并制定了以“四抗二平衡”为核心的有效治疗策略用于临床实践。“四抗二平衡”策略包括抗病毒、抗休克、抗低氧血症、抗继发感染,以及维持水、电解质和酸碱平衡及微生态平衡。同时,建议采用多学科综合个体化治疗以提高治疗效果。临床决策中强调了早期病毒学检测、炎症指标动态监测及胸部影像学检查的重要性。痰标本RT-PCR结果阳性率最高。急性期10%的患者血液样本可检测到病毒核酸,50%的患者粪便RT-PCR结果呈阳性。我们还从粪便中分离出活病毒株,表明粪便具有潜在传染性。动态细胞因子检测对于及时识别细胞因子风暴及应用人工肝血液净化系统很有必要。“四抗二平衡”策略有效提高了治愈率并降低了死亡率。早期抗病毒治疗可减轻疾病严重程度并防止病情进展,我们发现洛匹那韦/利托那韦联合阿比多尔对COVID-19有抗病毒作用。休克和低氧血症通常由细胞因子风暴引起。人工肝血液净化系统可迅速清除炎症介质并阻断细胞因子风暴。此外,它还有利于维持液体、电解质和酸碱平衡,从而提高危重症的治疗效果。对于重症病例,支持早期且短期使用中等剂量糖皮质激素。氧合指数低于200 mmHg的患者应转至重症医学中心。首选保守氧疗,不建议无创通气。机械通气患者应严格实施预防呼吸机相关性肺炎的集束化策略。除病程长、反复发热及降钙素原(PCT)升高的患者外,不建议预防性使用抗菌药物,同时应关注继发真菌感染。部分COVID-19患者表现出肠道微生物群失调,益生菌如[具体益生菌名称1]和[具体益生菌名称2]减少,因此应对所有患者进行营养及胃肠功能评估。建议给予营养支持并应用益生元或益生菌以调节肠道微生物群平衡,降低细菌易位导致继发感染的风险。COVID-19患者中焦虑和恐惧很常见。因此,我们建立了心理危机动态评估与预警机制。我们还将中医融入治疗,通过中医辨证方法促进疾病康复。我们优化了重症患者的护理流程以促进其康复。严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染后病毒清除模式仍不清楚。因此,出院患者需要隔离两周并进行定期随访。浙江的经验和建议已在我们中心实施并取得了良好效果。然而,由于COVID-19是一种新出现的疾病,仍需要开展更多工作以完善COVID-19的预防、诊断和治疗策略。